Acasti Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Acasti Pharma has a total shareholder equity of $64.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $76.2M and $11.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$25.11m |
Equity | US$64.68m |
Total liabilities | US$11.51m |
Total assets | US$76.19m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: A1P0's short term assets ($26.9M) exceed its short term liabilities ($1.8M).
Long Term Liabilities: A1P0's short term assets ($26.9M) exceed its long term liabilities ($9.7M).
Debt to Equity History and Analysis
Debt Level: A1P0 is debt free.
Reducing Debt: A1P0 has no debt compared to 5 years ago when its debt to equity ratio was 5.8%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A1P0 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A1P0 has sufficient cash runway for 1.7 years if free cash flow continues to grow at historical rates of 5.1% each year.